Ci Design announces its acquisition of Compounding Workflow, a laboratory design firm specializing in compounding pharmacy consulting. With the acquisition, Bryan Prince, the owner of Compounding Workflow, joins Ci Design as an Associate, Senior Lab Planner, and Compounding Specialist. The company also unveils a new office in Greenville, South Carolina.
Key Highlights
- Ci Design has acquired Compounding Workflow and opened a new office in Greenville.
- Bryan Prince, with expertise in compounding pharmacy consulting, joins Ci Design and emphasizes designing based on the business model rather than just square footage.
- Prince has a rich history of designing and consulting for over 200 compounding pharmacies in the US and has been a speaker at various industry events.
- Christopher Ladd, Co-Founder and Vice President of Ci Design, highlights the alignment of Prince’s dedication with Ci’s mission.
- Anna Evangelista, Associate and Director of Lab Planning for Ci Design, praises Prince’s expertise in elevating Ci’s design capabilities.
Source: Business Wire
Notable Quotes
- “We don’t design to the allotted square footage, instead we design to your business model…” – Bryan Prince, Owner of Compounding Workflow and Associate, Senior Lab Planner and Compounding Specialist at Ci Design
- “As the owner of Compounding Workflow, Bryan Prince and Ci share a commitment to the unique and customized needs of our clients in Science & Technology,” – Christopher Ladd, Co-Founder and Vice President of Ci Design
SoH's Take
The acquisition of Compounding Workflow by Ci Design signifies a strategic move to bolster their expertise in the realm of laboratory design, particularly in the compounding pharmacy sector. Bryan Prince’s inclusion in the Ci Design team not only adds a wealth of experience but also a unique perspective on designing based on business models. This acquisition, coupled with the opening of a new office, indicates Ci Design’s commitment to expanding its footprint and enhancing its service offerings. The collaboration is poised to set new benchmarks in the industry, especially in the domain of compounding pharmacy consulting.
